메뉴 건너뛰기




Volumn 40, Issue 3, 2011, Pages 541-559

Nonalcoholic Fatty Liver Disease: Pharmacologic and Surgical Options

Author keywords

Bariatric surgery; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Pioglitazone; Vitamin e

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETAINE; CLOFIBRATE; GLITAZONE DERIVATIVE; METFORMIN; PENTOXIFYLLINE; PIOGLITAZONE; PLACEBO; PROBUCOL; ROSIGLITAZONE; TETRAHYDROLIPSTATIN; URSODEOXYCHOLIC ACID;

EID: 80052380430     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.06.001     Document Type: Review
Times cited : (2)

References (89)
  • 1
    • 78651041767 scopus 로고
    • The liver in obesity
    • Zelman S. The liver in obesity. Arch Intern Med 1958, 90:141-156.
    • (1958) Arch Intern Med , vol.90 , pp. 141-156
    • Zelman, S.1
  • 2
    • 0016630274 scopus 로고
    • Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease
    • Peters R.L., Gay T., Reynolds T.B. Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 1975, 63:318-331.
    • (1975) Am J Clin Pathol , vol.63 , pp. 318-331
    • Peters, R.L.1    Gay, T.2    Reynolds, T.B.3
  • 3
    • 34249668818 scopus 로고    scopus 로고
    • Epidemiology and natural history of NAFLD and NASH
    • Ong J.P., Younossi Z.M. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007, 11:1-16.
    • (2007) Clin Liver Dis , vol.11 , pp. 1-16
    • Ong, J.P.1    Younossi, Z.M.2
  • 4
    • 0019152816 scopus 로고
    • Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
    • Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
    • (1980) Mayo Clin Proc , vol.55 , pp. 434-438
    • Ludwig, J.1    Viggiano, T.R.2    McGill, D.B.3
  • 5
    • 33645554182 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and liver transplantation
    • Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 2006, 12:523-534.
    • (2006) Liver Transpl , vol.12 , pp. 523-534
    • Angulo, P.1
  • 6
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
    • (2002) N Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 7
    • 33646852746 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    • Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006, 144:705-714.
    • (2006) Ann Intern Med , vol.144 , pp. 705-714
    • Armstrong, G.L.1    Wasley, A.2    Simard, E.P.3
  • 8
    • 11144264156 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: a review of current understanding and future impact
    • Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastro and Hepatol 2004, 2:1048-1058.
    • (2004) Clin Gastro and Hepatol , vol.2 , pp. 1048-1058
    • Charlton, M.1
  • 9
    • 0025178612 scopus 로고
    • The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years
    • Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
    • (1990) Hepatology , vol.11 , pp. 74-80
    • Powell, E.E.1    Cooksley, W.G.2    Hanson, R.3
  • 10
    • 0032695030 scopus 로고    scopus 로고
    • Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    • Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356-1362.
    • (1999) Hepatology , vol.30 , pp. 1356-1362
    • Angulo, P.1    Keach, J.C.2    Batts, K.P.3
  • 11
    • 0036724436 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
    • Evans C.D., Oien K.A., MacSween R.N., et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?. J Clin Pathol 2002, 55:689-692.
    • (2002) J Clin Pathol , vol.55 , pp. 689-692
    • Evans, C.D.1    Oien, K.A.2    MacSween, R.N.3
  • 12
    • 0141794560 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natural history?
    • Ong J.P., Younossi Z.M. Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natural history?. Am J Gastroenterol 2003, 98:1915-1917.
    • (2003) Am J Gastroenterol , vol.98 , pp. 1915-1917
    • Ong, J.P.1    Younossi, Z.M.2
  • 13
    • 11144351102 scopus 로고    scopus 로고
    • The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    • Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005, 42:132-138.
    • (2005) J Hepatol , vol.42 , pp. 132-138
    • Adams, L.A.1    Sanderson, S.2    Lindor, K.D.3
  • 14
    • 0141510580 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
    • Harrison S.A., Torgerson S., Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003, 98:2042-2047.
    • (2003) Am J Gastroenterol , vol.98 , pp. 2042-2047
    • Harrison, S.A.1    Torgerson, S.2    Hayashi, P.H.3
  • 15
    • 0035431018 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
    • Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
    • (2001) Diabetes , vol.50 , pp. 1844-1850
    • Marchesini, G.1    Brizi, M.2    Bianchi, G.3
  • 16
    • 53049101877 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
    • Aithal G.P., Thomas J.A., Kaye P.V., et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008, 135:1176-1184.
    • (2008) Gastroenterology , vol.135 , pp. 1176-1184
    • Aithal, G.P.1    Thomas, J.A.2    Kaye, P.V.3
  • 17
    • 75449116707 scopus 로고    scopus 로고
    • Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT 2) extension trial
    • Ratziu V., Charlotte F., Bernhardt C., et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT 2) extension trial. Hepatology 2010, 51:445-453.
    • (2010) Hepatology , vol.51 , pp. 445-453
    • Ratziu, V.1    Charlotte, F.2    Bernhardt, C.3
  • 18
    • 33751545838 scopus 로고    scopus 로고
    • A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    • Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006, 355:2297-2307.
    • (2006) N Engl J Med , vol.355 , pp. 2297-2307
    • Belfort, R.1    Harrison, S.A.2    Brown, K.3
  • 19
    • 77951874018 scopus 로고    scopus 로고
    • Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    • Sanyal A., Chalasani N., Kowdley K.V., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010, 362:1675-1685.
    • (2010) N Engl J Med , vol.362 , pp. 1675-1685
    • Sanyal, A.1    Chalasani, N.2    Kowdley, K.V.3
  • 20
    • 46349088361 scopus 로고    scopus 로고
    • Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial
    • Ratziu V., Giral P., Jacqueminet S., et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial. Gastroenterology 2008, 135:100-110.
    • (2008) Gastroenterology , vol.135 , pp. 100-110
    • Ratziu, V.1    Giral, P.2    Jacqueminet, S.3
  • 21
    • 74349125502 scopus 로고    scopus 로고
    • Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
    • Omer Z., Cetinkalp S., Akyildiz M., et al. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2010, 22:18-23.
    • (2010) Eur J Gastroenterol Hepatol , vol.22 , pp. 18-23
    • Omer, Z.1    Cetinkalp, S.2    Akyildiz, M.3
  • 22
    • 34548306770 scopus 로고    scopus 로고
    • The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
    • Lutchman G., Modi A., Kleiner D.E., et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007, 46:424-429.
    • (2007) Hepatology , vol.46 , pp. 424-429
    • Lutchman, G.1    Modi, A.2    Kleiner, D.E.3
  • 23
    • 34548200442 scopus 로고    scopus 로고
    • Pioglitazone treatment increases whole body fat but not total body water in patients with nonalcoholic steatohepatitis
    • Balas B., Belfort R., Harrison S.A., et al. Pioglitazone treatment increases whole body fat but not total body water in patients with nonalcoholic steatohepatitis. J Hepatology 2007, 47:565-570.
    • (2007) J Hepatology , vol.47 , pp. 565-570
    • Balas, B.1    Belfort, R.2    Harrison, S.A.3
  • 24
    • 0026638458 scopus 로고
    • Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver
    • Parola M., Muraca R., Dianzani I., et al. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett 1992, 308:267-270.
    • (1992) FEBS Lett , vol.308 , pp. 267-270
    • Parola, M.1    Muraca, R.2    Dianzani, I.3
  • 25
    • 0033025969 scopus 로고    scopus 로고
    • Comparisons of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey
    • Strauss R. Comparisons of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J Pediatr 1999, 134:160-165.
    • (1999) J Pediatr , vol.134 , pp. 160-165
    • Strauss, R.1
  • 26
    • 0034799895 scopus 로고    scopus 로고
    • Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis, a pilot study
    • Hasegawa T., Yoneda M., Nakamura K., et al. Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis, a pilot study. Aliment Pharmacol Ther 2001, 15:1667-1672.
    • (2001) Aliment Pharmacol Ther , vol.15 , pp. 1667-1672
    • Hasegawa, T.1    Yoneda, M.2    Nakamura, K.3
  • 27
    • 33947400987 scopus 로고    scopus 로고
    • Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with nonalcoholic steatohepatitis, results of a pilot study
    • Yakaryilmaz F., Guliter S., Savas B., et al. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with nonalcoholic steatohepatitis, results of a pilot study. Intern Med J 2007, 37:229-235.
    • (2007) Intern Med J , vol.37 , pp. 229-235
    • Yakaryilmaz, F.1    Guliter, S.2    Savas, B.3
  • 28
    • 0344742265 scopus 로고    scopus 로고
    • Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
    • Harrison S.A., Torgerson S., Hayashi P., et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003, 98:2485-2490.
    • (2003) Am J Gastroenterol , vol.98 , pp. 2485-2490
    • Harrison, S.A.1    Torgerson, S.2    Hayashi, P.3
  • 29
    • 33845336554 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis
    • Dufour J.F., Oneta C.M., Gonvers J.J., et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2006, 4:1537-1543.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 1537-1543
    • Dufour, J.F.1    Oneta, C.M.2    Gonvers, J.J.3
  • 30
    • 14944359845 scopus 로고    scopus 로고
    • A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
    • Sanyal A., Mofrad P., Contos M., et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004, 2:1107-1115.
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 1107-1115
    • Sanyal, A.1    Mofrad, P.2    Contos, M.3
  • 31
    • 19944427642 scopus 로고    scopus 로고
    • Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality
    • Miller E.R., Pastor-Barriuso R., Dalal D., et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
    • (2005) Ann Intern Med , vol.142 , pp. 37-46
    • Miller, E.R.1    Pastor-Barriuso, R.2    Dalal, D.3
  • 32
    • 0034773404 scopus 로고    scopus 로고
    • Role of AMP-activated protein kinase in mechanism of metformin action
    • Zhou G., Myers R., Li Y., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
    • (2001) J Clin Invest , vol.108 , pp. 1167-1174
    • Zhou, G.1    Myers, R.2    Li, Y.3
  • 33
    • 38049131878 scopus 로고    scopus 로고
    • Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with nonalcoholic steatohepatitis
    • De Oliveira C.P., Stefano J.D., de Siueira E.R., et al. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with nonalcoholic steatohepatitis. Hepatol Res 2008, 38:159-165.
    • (2008) Hepatol Res , vol.38 , pp. 159-165
    • De Oliveira, C.P.1    Stefano, J.D.2    de Siueira, E.R.3
  • 34
    • 0035883890 scopus 로고    scopus 로고
    • Metformin in nonalcoholic steatohepatitis
    • Marchesini G., Brizi M., Bianchi G., et al. Metformin in nonalcoholic steatohepatitis. Lancet 2001, 358:893-894.
    • (2001) Lancet , vol.358 , pp. 893-894
    • Marchesini, G.1    Brizi, M.2    Bianchi, G.3
  • 35
    • 1642296465 scopus 로고    scopus 로고
    • Metformin in the treatment of patients with nonalcoholic steatohepatitis
    • Uygun A., Kadayifici A., Isik A.T., et al. Metformin in the treatment of patients with nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2004, 19:537-544.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 537-544
    • Uygun, A.1    Kadayifici, A.2    Isik, A.T.3
  • 36
    • 3142670354 scopus 로고    scopus 로고
    • Metformin in the treatment of nonalcoholic steatohepatitis: a pilot open label trial
    • Nair S., Diehl A.M., Wiseman M., et al. Metformin in the treatment of nonalcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004, 20:23-28.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 23-28
    • Nair, S.1    Diehl, A.M.2    Wiseman, M.3
  • 37
    • 57649229536 scopus 로고    scopus 로고
    • Pilot study of metformin for the treatment of nonalcoholic steatohepatitis
    • Loomba R., Lutchman G., Kleiner D.E., et al. Pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2009, 29:172-182.
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 172-182
    • Loomba, R.1    Lutchman, G.2    Kleiner, D.E.3
  • 38
    • 19144365586 scopus 로고    scopus 로고
    • A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
    • Bugianesi E., Gentilcore E., Manini R., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005, 100:1082-1090.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1082-1090
    • Bugianesi, E.1    Gentilcore, E.2    Manini, R.3
  • 39
    • 77955470801 scopus 로고    scopus 로고
    • Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
    • Garinis G.A., Fruci B., Mazza A., et al. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes 2010, 34:1255-1264.
    • (2010) Int J Obes , vol.34 , pp. 1255-1264
    • Garinis, G.A.1    Fruci, B.2    Mazza, A.3
  • 40
    • 0037372390 scopus 로고    scopus 로고
    • Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study
    • Merat S., Malekzadeh R., Sohrabi M.R., et al. Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol 2003, 36:266-268.
    • (2003) J Clin Gastroenterol , vol.36 , pp. 266-268
    • Merat, S.1    Malekzadeh, R.2    Sohrabi, M.R.3
  • 41
    • 0037383865 scopus 로고    scopus 로고
    • Probucol in the treatment of nonalcoholic steatohepatitis: a double-blind randomized controlled study
    • Merat S., Malekzadeh R., Sohrabi M.R., et al. Probucol in the treatment of nonalcoholic steatohepatitis: a double-blind randomized controlled study. J Hepatol 2003, 38:414-418.
    • (2003) J Hepatol , vol.38 , pp. 414-418
    • Merat, S.1    Malekzadeh, R.2    Sohrabi, M.R.3
  • 42
    • 46449124024 scopus 로고    scopus 로고
    • Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol
    • Merat S., Aduli M., Kazemi R., et al. Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. Dig Dis Sci 2008, 53:2246-2250.
    • (2008) Dig Dis Sci , vol.53 , pp. 2246-2250
    • Merat, S.1    Aduli, M.2    Kazemi, R.3
  • 43
    • 11144249271 scopus 로고    scopus 로고
    • A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
    • Adams L.A., Zein C.O., Angulo P., et al. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99:2365-2368.
    • (2004) Am J Gastroenterol , vol.99 , pp. 2365-2368
    • Adams, L.A.1    Zein, C.O.2    Angulo, P.3
  • 44
    • 7044269614 scopus 로고    scopus 로고
    • Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
    • Satapathy S.K., Garg S., Chauhan, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99:1946-1952.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1946-1952
    • Satapathy, S.K.1    Garg, S.C.2
  • 45
    • 34247210640 scopus 로고    scopus 로고
    • Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis, and necroinflammation in patients with nonalcoholic steatohepatitis
    • Satapathy S.K., Sakhuja P., Malhotra V., et al. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis, and necroinflammation in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2007, 22:634-638.
    • (2007) J Gastroenterol Hepatol , vol.22 , pp. 634-638
    • Satapathy, S.K.1    Sakhuja, P.2    Malhotra, V.3
  • 46
    • 69749088832 scopus 로고    scopus 로고
    • A randomized controlled pilot study of pentoxifylline in patients with nonalcoholic steatohepatitis
    • Lee Y.M., Sutedja D.S., Wai C.T., et al. A randomized controlled pilot study of pentoxifylline in patients with nonalcoholic steatohepatitis. Hepatol Int 2008, 2:196-201.
    • (2008) Hepatol Int , vol.2 , pp. 196-201
    • Lee, Y.M.1    Sutedja, D.S.2    Wai, C.T.3
  • 47
    • 35349024283 scopus 로고    scopus 로고
    • Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis
    • Song Z., Deaciuc I., Zhou Z., et al. Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 2007, 293:894-902.
    • (2007) Am J Physiol Gastrointest Liver Physiol , vol.293 , pp. 894-902
    • Song, Z.1    Deaciuc, I.2    Zhou, Z.3
  • 48
    • 0034834208 scopus 로고    scopus 로고
    • Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study
    • Abdelmalek M.F., Angulo P., Jorgensen R.A., et al. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001, 96:2711-2717.
    • (2001) Am J Gastroenterol , vol.96 , pp. 2711-2717
    • Abdelmalek, M.F.1    Angulo, P.2    Jorgensen, R.A.3
  • 49
    • 73149092115 scopus 로고    scopus 로고
    • Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial
    • Abdelmalek M.F., Sanderson S.O., Angulo P., et al. Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial. Hepatology 2009, 50:1818-1826.
    • (2009) Hepatology , vol.50 , pp. 1818-1826
    • Abdelmalek, M.F.1    Sanderson, S.O.2    Angulo, P.3
  • 50
    • 0034942512 scopus 로고    scopus 로고
    • The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent
    • Rodrigues C.M., Steer C.J. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. Expert Opin Investig Drugs 2001, 10:1243-1253.
    • (2001) Expert Opin Investig Drugs , vol.10 , pp. 1243-1253
    • Rodrigues, C.M.1    Steer, C.J.2
  • 51
    • 0031950282 scopus 로고    scopus 로고
    • Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production
    • Rodrigues C.M., Fan G., Wong P.Y., et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998, 4:165-178.
    • (1998) Mol Med , vol.4 , pp. 165-178
    • Rodrigues, C.M.1    Fan, G.2    Wong, P.Y.3
  • 52
    • 84933047295 scopus 로고    scopus 로고
    • Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis: a pilot study
    • Laurin J., Lindor K.D., Crippin J.S., et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis: a pilot study. Hepatology 1996, 23:1464-1467.
    • (1996) Hepatology , vol.23 , pp. 1464-1467
    • Laurin, J.1    Lindor, K.D.2    Crippin, J.S.3
  • 53
    • 1542515099 scopus 로고    scopus 로고
    • Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial
    • Lindor K.D., Kowdley K.V., Heathcote E.J., et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial. Hepatology 2004, 39:770-778.
    • (2004) Hepatology , vol.39 , pp. 770-778
    • Lindor, K.D.1    Kowdley, K.V.2    Heathcote, E.J.3
  • 54
    • 77958100236 scopus 로고    scopus 로고
    • A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis
    • Adams L.A., Angulo P., Petz J., et al. A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis. Hepatol Int 2010, 4:628-633.
    • (2010) Hepatol Int , vol.4 , pp. 628-633
    • Adams, L.A.1    Angulo, P.2    Petz, J.3
  • 55
    • 77955699301 scopus 로고    scopus 로고
    • High-dose ursodeoxycholic acid therapy for the treatment of nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
    • Leuschner U.F., Lindenthal B., Hermann G., et al. High-dose ursodeoxycholic acid therapy for the treatment of nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology 2010, 52:472-479.
    • (2010) Hepatology , vol.52 , pp. 472-479
    • Leuschner, U.F.1    Lindenthal, B.2    Hermann, G.3
  • 56
    • 79954764140 scopus 로고    scopus 로고
    • A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis
    • Ratziu V., de Ledinghen V., Oberti F., et al. A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2010, 54:1011-1019.
    • (2010) J Hepatol , vol.54 , pp. 1011-1019
    • Ratziu, V.1    de Ledinghen, V.2    Oberti, F.3
  • 57
    • 27744490794 scopus 로고    scopus 로고
    • Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
    • Suzuki A., Lindor K., St Saver J., et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005, 43:1060-1066.
    • (2005) J Hepatol , vol.43 , pp. 1060-1066
    • Suzuki, A.1    Lindor, K.2    St Saver, J.3
  • 58
    • 0025959287 scopus 로고
    • Hepatic effects of dietary weight loss in morbidly obese subjects
    • Andersen T., Gluud C., Franzmann M., et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991, 12:224-229.
    • (1991) J Hepatol , vol.12 , pp. 224-229
    • Andersen, T.1    Gluud, C.2    Franzmann, M.3
  • 59
    • 19144372447 scopus 로고    scopus 로고
    • One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study
    • Huang M., Greenson J., Chao C., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005, 100:1072-1081.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1072-1081
    • Huang, M.1    Greenson, J.2    Chao, C.3
  • 60
    • 58949102847 scopus 로고    scopus 로고
    • Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial
    • Harrison S.A., Fecht W., Brunt E.M., et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 2009, 49:80-86.
    • (2009) Hepatology , vol.49 , pp. 80-86
    • Harrison, S.A.1    Fecht, W.2    Brunt, E.M.3
  • 61
    • 78651242073 scopus 로고    scopus 로고
    • BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons
    • Lopez-Nava G., Rubio M.A., Prados S., et al. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011, 21:5-9.
    • (2011) Obes Surg , vol.21 , pp. 5-9
    • Lopez-Nava, G.1    Rubio, M.A.2    Prados, S.3
  • 62
    • 70349763599 scopus 로고    scopus 로고
    • Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study
    • Genco A., Cipriano M., Materia A., et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc 2009, 23:1849-1853.
    • (2009) Surg Endosc , vol.23 , pp. 1849-1853
    • Genco, A.1    Cipriano, M.2    Materia, A.3
  • 63
    • 53849086533 scopus 로고    scopus 로고
    • Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients
    • Ricci G., Bersani G., Rossi A., et al. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 2008, 18:1438-1442.
    • (2008) Obes Surg , vol.18 , pp. 1438-1442
    • Ricci, G.1    Bersani, G.2    Rossi, A.3
  • 64
    • 77951623680 scopus 로고    scopus 로고
    • Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients
    • Forlano R., Ippolito A.M., Iacobellis A., et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010, 71:927-933.
    • (2010) Gastrointest Endosc , vol.71 , pp. 927-933
    • Forlano, R.1    Ippolito, A.M.2    Iacobellis, A.3
  • 65
    • 0026353971 scopus 로고
    • Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel
    • NIH conference
    • Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991, 115:956-961. NIH conference.
    • (1991) Ann Intern Med , vol.115 , pp. 956-961
  • 66
    • 70349310620 scopus 로고    scopus 로고
    • American Society for Metabolic and Bariatric Surgery (2009), Accessed June 7, 2011
    • Fact sheet: metabolic & bariatric surgery American Society for Metabolic and Bariatric Surgery (2009), Accessed June 7, 2011. http://www.asbs.org.
    • Fact sheet: metabolic & bariatric surgery
  • 67
    • 52949106040 scopus 로고    scopus 로고
    • Gastric banding or bypass?. A systematic review comparing the two most popular bariatric procedures
    • Tice J.A., Karliner L., Walsh J., et al. Gastric banding or bypass?. A systematic review comparing the two most popular bariatric procedures. Am J Med 2008, 121:885-893.
    • (2008) Am J Med , vol.121 , pp. 885-893
    • Tice, J.A.1    Karliner, L.2    Walsh, J.3
  • 68
    • 26444467171 scopus 로고    scopus 로고
    • Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome
    • Mattar S.G., Velcu L.M., Rabinovitz M., et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005, 242:610-617.
    • (2005) Ann Surg , vol.242 , pp. 610-617
    • Mattar, S.G.1    Velcu, L.M.2    Rabinovitz, M.3
  • 69
    • 32044451685 scopus 로고    scopus 로고
    • Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
    • Clark J.M., Alkhuraishi A.R., Solga S.F., et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 2005, 13:1180-1186.
    • (2005) Obes Res , vol.13 , pp. 1180-1186
    • Clark, J.M.1    Alkhuraishi, A.R.2    Solga, S.F.3
  • 70
    • 2542546652 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
    • Dixon J.B., Bhathal P.S., Hughes N.R., et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004, 39:1647-1654.
    • (2004) Hepatology , vol.39 , pp. 1647-1654
    • Dixon, J.B.1    Bhathal, P.S.2    Hughes, N.R.3
  • 71
    • 33750571872 scopus 로고    scopus 로고
    • Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement
    • Dixon J.B., Bhathal P.S., O'Brien P.E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006, 16:1278-1286.
    • (2006) Obes Surg , vol.16 , pp. 1278-1286
    • Dixon, J.B.1    Bhathal, P.S.2    O'Brien, P.E.3
  • 72
    • 25844522508 scopus 로고    scopus 로고
    • Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity
    • Stratopoulos C., Papakonstantinou A., Terzis I., et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005, 15:1154-1160.
    • (2005) Obes Surg , vol.15 , pp. 1154-1160
    • Stratopoulos, C.1    Papakonstantinou, A.2    Terzis, I.3
  • 73
    • 0348047323 scopus 로고    scopus 로고
    • Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
    • Kral J.G., Thung S.N., Biron S., et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004, 135:48-58.
    • (2004) Surgery , vol.135 , pp. 48-58
    • Kral, J.G.1    Thung, S.N.2    Biron, S.3
  • 74
    • 57149101692 scopus 로고    scopus 로고
    • Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis
    • Mummadi R.R., Kasturi K.S., Chennareddygari S., et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2008, 6:1396-1402.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1396-1402
    • Mummadi, R.R.1    Kasturi, K.S.2    Chennareddygari, S.3
  • 76
    • 67650951419 scopus 로고    scopus 로고
    • Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease
    • Mathurin P., Hollebecque A., Arnalsteen L., et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009, 137:532-540.
    • (2009) Gastroenterology , vol.137 , pp. 532-540
    • Mathurin, P.1    Hollebecque, A.2    Arnalsteen, L.3
  • 77
    • 79955767080 scopus 로고    scopus 로고
    • NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery-a prospective analysis
    • Ribeireiro T., Swain J., Sarr M., et al. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery-a prospective analysis. Obes Surg 2011, 21:310-315.
    • (2011) Obes Surg , vol.21 , pp. 310-315
    • Ribeireiro, T.1    Swain, J.2    Sarr, M.3
  • 78
    • 68049123594 scopus 로고    scopus 로고
    • Perioperative safety in the longitudinal assessment of bariatric surgery
    • Longitudinal Assessment of Bariatric Surgery (LABS) Consortium
    • Flum D.R., Belle S.H., King W.C., et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009, 361:445-454. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.
    • (2009) N Engl J Med , vol.361 , pp. 445-454
    • Flum, D.R.1    Belle, S.H.2    King, W.C.3
  • 79
    • 46049092991 scopus 로고    scopus 로고
    • Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery
    • D'Albuquerque L.A., Gonzalez A.M., Wahle R.C., et al. Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery. Liver Transpl 2008, 14:881-885.
    • (2008) Liver Transpl , vol.14 , pp. 881-885
    • D'Albuquerque, L.A.1    Gonzalez, A.M.2    Wahle, R.C.3
  • 80
    • 16544390906 scopus 로고    scopus 로고
    • Hepatic decompensation after gastric bypass surgery for severe obesity
    • Cotler S.J., Vitello J.M., Guzman G., et al. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci 2004, 49:1563-1568.
    • (2004) Dig Dis Sci , vol.49 , pp. 1563-1568
    • Cotler, S.J.1    Vitello, J.M.2    Guzman, G.3
  • 81
    • 63349098164 scopus 로고    scopus 로고
    • Outcome after liver transplantation for NASH cirrhosis
    • Malik S.M., deVera M.E., Fontes P., et al. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009, 9:782-793.
    • (2009) Am J Transplant , vol.9 , pp. 782-793
    • Malik, S.M.1    deVera, M.E.2    Fontes, P.3
  • 82
    • 71249149460 scopus 로고    scopus 로고
    • Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease
    • Bhagat V., Mindikoglu A.L., Nudo C.G., et al. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009, 15:1814-1820.
    • (2009) Liver Transpl , vol.15 , pp. 1814-1820
    • Bhagat, V.1    Mindikoglu, A.L.2    Nudo, C.G.3
  • 83
    • 71249126103 scopus 로고    scopus 로고
    • Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis
    • Malik S.M., Devera M.E., Fontes P., et al. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl 2009, 15:1843-1851.
    • (2009) Liver Transpl , vol.15 , pp. 1843-1851
    • Malik, S.M.1    Devera, M.E.2    Fontes, P.3
  • 84
    • 77950639727 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
    • Yalamanchili K., Saadeh S., Klintmalm G.B., et al. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010, 16:431-439.
    • (2010) Liver Transpl , vol.16 , pp. 431-439
    • Yalamanchili, K.1    Saadeh, S.2    Klintmalm, G.B.3
  • 85
    • 79952758351 scopus 로고    scopus 로고
    • NAFLD recurrence in liver transplant recipients
    • Dureja P., Mellinger J., Agni R., et al. NAFLD recurrence in liver transplant recipients. Transplantation 2011, 91:684-689.
    • (2011) Transplantation , vol.91 , pp. 684-689
    • Dureja, P.1    Mellinger, J.2    Agni, R.3
  • 86
    • 79251488789 scopus 로고    scopus 로고
    • Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events
    • Laish I., Braun M., Mor E., et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011, 17:15-22.
    • (2011) Liver Transpl , vol.17 , pp. 15-22
    • Laish, I.1    Braun, M.2    Mor, E.3
  • 87
    • 71249127127 scopus 로고    scopus 로고
    • Posttransplant metabolic syndrome: an epidemic waiting to happen
    • Pagadala M., Dasarathy S., Eghtesad B., et al. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009, 15:1662-1670.
    • (2009) Liver Transpl , vol.15 , pp. 1662-1670
    • Pagadala, M.1    Dasarathy, S.2    Eghtesad, B.3
  • 88
    • 0141532275 scopus 로고    scopus 로고
    • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
    • Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003, 38:1008-1017.
    • (2003) Hepatology , vol.38 , pp. 1008-1017
    • Neuschwander-Tetri, B.A.1    Brunt, E.M.2    Wehmeier, K.R.3
  • 89
    • 70350662659 scopus 로고    scopus 로고
    • Metformin in patients with nonalcoholic fatty liver disease: a randomized, controlled trial
    • Haukeland J.W., Konopski Z., Eggesbo H.B., et al. Metformin in patients with nonalcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 2009, 44:853-860.
    • (2009) Scand J Gastroenterol , vol.44 , pp. 853-860
    • Haukeland, J.W.1    Konopski, Z.2    Eggesbo, H.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.